Staphylococcus aureus persistence in non-professional phagocytes

International Journal of Medical Microbiology

Volumn 304, Issue 2, 2014, Pages 170-176

  Löffler, Bettina ^a   Tuchscherr, Lorena ^a   Niemann, Silke ^a   Peters, Georg ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Chronic infections; Immune escape; Intracellular bacterial persistence; Phagosomal escape; S. aureus host cell invasion

Indexed keywords

ADAPTATION; BACTERIAL VIRULENCE; BACTERIUM MUTANT; CELL INVASION; CHRONIC DISEASE; CYTOTOXICITY; DEGRADATION; HOST CELL; INFLAMMATION; INTRACELLULAR SPACE; NONHUMAN; PHAGOCYTE; PHENOTYPE; SHORT SURVEY; STAPHYLOCOCCUS AUREUS;

CHRONIC INFECTIONS; IMMUNE ESCAPE; INTRACELLULAR BACTERIAL PERSISTENCE; PHAGOSOMAL ESCAPE; S. AUREUS HOST CELL INVASION;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; HUMANS; IMMUNE EVASION; PHAGOCYTES; PHAGOSOMES; STAPHYLOCOCCUS AUREUS;

EID: 84893778503     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2013.11.011     Document Type: Short Survey

References (82)

1. Ahmed S., Meghji S., Williams R.J., Henderson B., Brock J.H., Nair S.P. Staphylococcus aureus fibronectin binding proteins are essential for internalization by osteoblasts but do not account for differences in intracellular levels of bacteria. Infect. Immun. 2001, 69:2872-2877.
2. Archer N.K., Mazaitis M.J., Costerton J.W., Leid J.G., Powers M.E., Shirtliff M.E. Staphylococcus aureus biofilms: properties, regulation, and roles in human disease. Virulence 2011, 2:445-459.
3. Atalla H., Gyles C., Mallard B. Persistence of a Staphylococcus aureus small colony variants (S. aureus SCV) within bovine mammary epithelial cells. Vet. Microbiol. 2010, 143:319-328.
4. Bantel H., Sinha B., Domschke W., Peters G., Schulze-Osthoff K., Janicke R.U. alpha-Toxin is a mediator of Staphylococcus aureus-induced cell death and activates caspases via the intrinsic death pathway independently of death receptor signaling. J. Cell Biol. 2001, 155:637-648.
5. Baumert N., von E.C., Schaaff F., Peters G., Proctor R.A., Sahl H.G. Physiology and antibiotic susceptibility of Staphylococcus aureus small colony variants. Microb. Drug Resist. 2002, 8:253-260.
6. Bayles K.W., Wesson C.A., Liou L.E., Fox L.K., Bohach G.A., Trumble W.R. Intracellular Staphylococcus aureus escapes the endosome and induces apoptosis in epithelial cells. Infect. Immun. 1998, 66:336-342.
7. Bhakdi S., Tranum-Jensen J. Alpha-toxin of Staphylococcus aureus. Microbiol. Rev. 1991, 55:733-751.
8. Bost K.L., Ramp W.K., Nicholson N.C., Bento J.L., Marriott I., Hudson M.C. Staphylococcus aureus infection of mouse or human osteoblasts induces high levels of interleukin-6 and interleukin-12 production. J. Infect. Dis. 1999, 180:1912-1920.
9. Campoy E., Colombo M.I. Autophagy in intracellular bacterial infection. Biochim. Biophys. Acta 2009, 1793:1465-1477.
10. Chatterjee S.S., Joo H.S., Duong A.C., Dieringer T.D., Tan V.Y., Song Y., Fischer E.R., Cheung G.Y., Li M., Otto M. Essential Staphylococcus aureus toxin export system. Nat. Med. 2013, 19:364-367.
11. Chavakis T., Wiechmann K., Preissner K.T., Herrmann M. Staphylococcus aureus interactions with the endothelium: the role of bacterial "secretable expanded repertoire adhesive molecules" (SERAM) in disturbing host defense systems. Thromb. Haemost. 2005, 94:278-285.
12. Cheung A.L., Bayer A.S., Zhang G., Gresham H., Xiong Y.Q. Regulation of virulence determinants in vitro and in vivo in Staphylococcus aureus. FEMS Immunol. Med. Microbiol. 2004, 40:1-9.
13. Clarke S.R., Foster S.J. Surface adhesins of Staphylococcus aureus. Adv. Microb. Physiol. 2006, 51:187-224.
14. Deretic V. Autophagy in innate and adaptive immunity. Trends Immunol. 2005, 26:523-528.
15. Ellington J.K., Reilly S.S., Ramp W.K., Smeltzer M.S., Kellam J.F., Hudson M.C. Mechanisms of Staphylococcus aureus invasion of cultured osteoblasts. Microb. Pathog. 1999, 26:317-323.
16. Foster T.J., Hook M. Surface protein adhesins of Staphylococcus aureus. Trends Microbiol. 1998, 6:484-488.
17. Fowler T., Wann E.R., Joh D., Johansson S., Foster T.J., Hook M. Cellular invasion by Staphylococcus aureus involves a fibronectin bridge between the bacterial fibronectin-binding MSCRAMMs and host cell beta1 integrins. Eur. J. Cell Biol. 2000, 79:672-679.
18. Fraunholz M., Sinha B. Intracellular staphylococcus aureus: live-in and let die. Front. Cell Infect. Microbiol. 2012, 2:43.
19. Gasper N.A., Petty C.C., Schrum L.W., Marriott I., Bost K.L. Bacterium-induced CXCL10 secretion by osteoblasts can be mediated in part through toll-like receptor 4. Infect. Immun. 2002, 70:4075-4082.
20. Giese B., Dittmann S., Paprotka K., Levin K., Weltrowski A., Biehler D., Lam T.T., Sinha B., Fraunholz M.J. Staphylococcal alpha-toxin is not sufficient to mediate escape from phagolysosomes in upper-airway epithelial cells. Infect. Immun. 2009, 77:3611-3625.
21. Giese B., Glowinski F., Paprotka K., Dittmann S., Steiner T., Sinha B., Fraunholz M.J. Expression of delta-toxin by Staphylococcus aureus mediates escape from phago-endosomes of human epithelial and endothelial cells in the presence of beta-toxin. Cell Microbiol. 2011, 13:316-329.
22. Grundmeier M., Tuchscherr L., Brück M., Viemann D., Roth J., Willscher E., Becker K., Peters G., Löffler B. Staphylococcal strains vary greatly in their ability to induce an inflammatory response in endothelial cells. J. Infect. Dis. 2010, 201:871-880.
23. Haslinger B., Strangfeld K., Peters G., Schulze-Osthoff K., Sinha B. Staphylococcus aureus alpha-toxin induces apoptosis in peripheral blood mononuclear cells: role of endogenous tumour necrosis factor-alpha and the mitochondrial death pathway. Cell Microbiol. 2003, 5:729-741.
24. Haslinger-Löffler B., Kahl B.C., Grundmeier M., Strangfeld K., Wagner B., Fischer U., Cheung A.L., Peters G., Schulze-Osthoff K., Sinha B. Multiple virulence factors are required for Staphylococcus aureus-induced apoptosis in endothelial cells. Cell Microbiol. 2005, 7:1087-1097.
25. Horst S.A., Hoerr V., Beineke A., Kreis C., Tuchscherr L., Kalinka J., Lehne S., Schleicher I., Kohler G., Fuchs T., Raschke M.J., Rohde M., Peters G., Faber C., Löffler B., Medina E. A novel mouse model of Staphylococcus aureus chronic osteomyelitis that closely mimics the human infection: an integrated view of disease pathogenesis. Am. J. Pathol. 2012, 181:1206-1214.
26. Hudson M.C., Ramp W.K., Nicholson N.C., Williams A.S., Nousiainen M.T. Internalization of Staphylococcus aureus by cultured osteoblasts. Microb. Pathog. 1995, 19:409-419.
27. Inoshima I., Inoshima N., Wilke G.A., Powers M.E., Frank K.M., Wang Y., Bubeck W.J. A Staphylococcus aureus pore-forming toxin subverts the activity of ADAM10 to cause lethal infection in mice. Nat. Med. 2011, 17:1310-1314.
28. Jarry T.M., Cheung A.L. Staphylococcus aureus escapes more efficiently from the phagosome of a cystic fibrosis bronchial epithelial cell line than from its normal counterpart. Infect. Immun. 2006, 74:2568-2577.
29. Jauregui C.E., Mansell J.P., Jepson M.A., Jenkinson H.F. Differential interactions of Streptococcus gordonii and Staphylococcus aureus with cultured osteoblasts. Mol. Oral Microbiol. 2013, 28:250-266.
30. Kahl B.C., Cheung A. Internalization, intracellular replication and induction of apoptosis (IRA) of different Staphylococcus aureus strains and assorted mutants. 9th International Symposium on Staphylococci and Staphylococcal Infections GP31 2000.
31. Kahl B.C., Goulian M., van Wamel W., Herrmann M., Simon S.M., Kaplan G., Peters G., Cheung A.L. Staphylococcus aureus RN6390 replicates and induces apoptosis in a pulmonary epithelial cell line. Infect. Immun. 2000, 68:5385-5392.
32. Kintarak S., Whawell S.A., Speight P.M., Packer S., Nair S.P. Internalization of Staphylococcus aureus by human keratinocytes. Infect. Immun. 2004, 72:5668-5675.
33. Kornblum J., Kreiswirth B.N., Projan S.J., Ross H., Novick R. Agr: a polycistronic locus regulating exoprotein synthesis in Staphylococcus aureus. Molecular Biology of the Staphylococci 1990, 373-402. VCH Publishers, New York. R. Novick (Ed.).
34. Kretschmer D., Gleske A.K., Rautenberg M., Wang R., Koberle M., Bohn E., Schoneberg T., Rabiet M.J., Boulay F., Klebanoff S.J., van Kessel K.A., van Strijp J.A., Otto M., Peschel A. Human formyl peptide receptor 2 senses highly pathogenic Staphylococcus aureus. Cell Host Microbe 2010, 7:463-473.
35. Kriegeskorte A., Konig S., Sander G., Pirkl A., Mahabir E., Proctor R.A., von E.C., Peters G., Becker K. Small colony variants of Staphylococcus aureus reveal distinct protein profiles. Proteomics 2011, 11:2476-2490.
36. Krut O., Sommer H., Kronke M. Antibiotic-induced persistence of cytotoxic Staphylococcus aureus in non-phagocytic cells. J. Antimicrob. Chemother. 2004, 53:167-173.
37. Kubica M., Guzik K., Koziel J., Zarebski M., Richter W., Gajkowska B., Golda A., Maciag-Gudowska A., Brix K., Shaw L., Foster T., Potempa J. A potential new pathway for Staphylococcus aureus dissemination: the silent survival of S. aureus phagocytosed by human monocyte-derived macrophages. PLoS One 2008, 3:e1409.
38. Lam T.T., Giese B., Chikkaballi D., Kuhn A., Wolber W., Pane-Farre J., Schafer D., Engelmann S., Fraunholz M., Sinha B. Phagolysosomal integrity is generally maintained after Staphylococcus aureus invasion of nonprofessional phagocytes but is modulated by strain 6850. Infect. Immun. 2010, 78:3392-3403.
39. Lerena M.C., Vazquez C.L., Colombo M.I. Bacterial pathogens and the autophagic response. Cell Microbiol. 2010, 12:10-18.
40. Lew D.P., Waldvogel F.A. Osteomyelitis. Lancet 2004, 364:369-379.
41. Lowy F.D. Staphylococcus aureus infections. N. Engl. J. Med. 1998, 339:520-532.
42. Lowy F.D., Fant J., Higgins L.L., Ogawa S.K., Hatcher V.B. Staphylococcus aureus - human endothelial cell interactions. J. Ultrastruct. Mol. Struct. Res. 1988, 98:137-146.
43. Massey R.C., Kantzanou M.N., Fowler T., Day N.P., Schofield K., Wann E.R., Berendt A.R., Hook M., Peacock S.J. Fibronectin-binding protein A of Staphylococcus aureus has multiple, substituting, binding regions that mediate adherence to fibronectin and invasion of endothelial cells. Cell Microbiol. 2001, 3:839-851.
44. Mempel M., Schnopp C., Hojka M., Fesq H., Weidinger S., Schaller M., Korting H.C., Ring J., Abeck D. Invasion of human keratinocytes by Staphylococcus aureus and intracellular bacterial persistence represent haemolysin-independent virulence mechanisms that are followed by features of necrotic and apoptotic keratinocyte cell death. Br. J. Dermatol. 2002, 146:943-951.
45. Menzies B.E., Kourteva I. Internalization of Staphylococcus aureus by endothelial cells induces apoptosis. Infect. Immun. 1998, 66:5994-5998.
46. Menzies B.E., Kourteva I. Staphylococcus aureus alpha-toxin induces apoptosis in endothelial cells. FEMS Immunol. Med. Microbiol. 2000, 29:39-45.
47. Mestre M.B., Colombo M.I. Autophagy and toxins: a matter of life or death. Curr. Mol. Med. 2013, 13:241-251.
48. Murai M., Sakurada J., Seki K., Shinji H., Hirota Y., Masuda S. Apoptosis observed in BALB/3T3 cells having ingested Staphylococcus aureus. Microbiol. Immunol. 1999, 43:653-661.
49. Nuzzo I., Sanges M.R., Folgore A., Carratelli C.R. Apoptosis of human keratinocytes after bacterial invasion. FEMS Immunol. Med. Microbiol. 2000, 27:235-240.
50. Olivier A.C., Lemaire S., Van B.F., Tulkens P.M., Oldfield E. Role of rsbU and staphyloxanthin in phagocytosis and intracellular growth of Staphylococcus aureus in human macrophages and endothelial cells. J. Infect. Dis. 2009, 200:1367-1370.
51. Park S.Y., Chong Y.P., Park H.J., Park K.H., Moon S.M., Jeong J.Y., Kim M.N., Kim S.H., Lee S.O., Choi S.H., Woo J.H., Kim Y.S. agr Dysfunction and persistent methicillin-resistant Staphylococcus aureus bacteremia in patients with removed eradicable foci. Infection 2013, 41:111-119.
52. Powers M.E., Kim H.K., Wang Y., Bubeck W.J. ADAM10 mediates vascular injury induced by Staphylococcus aureus alpha-hemolysin. J. Infect. Dis. 2012, 206:352-356.
53. Proctor R.A., van Langevelde P., Kristjansson M., Maslow J.N., Arbeit R.D. Persistent and relapsing infections associated with small-colony variants of Staphylococcus aureus. Clin. Infect. Dis. 1995, 20:95-102.
54. Proctor R.A., von Eiff C., Kahl B.C., Becker K., McNamara P., Herrmann M., Peters G. Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat. Rev. Microbiol. 2006, 4:295-305.
55. Queck S.Y., Jameson-Lee M., Villaruz A.E., Bach T.H., Khan B.A., Sturdevant D.E., Ricklefs S.M., Li M., Otto M. RNAIII-independent target gene control by the agr quorum-sensing system: insight into the evolution of virulence regulation in Staphylococcus aureus. Mol. Cell 2008, 32:150-158.
56. Rao N., Ziran B.H., Lipsky B.A. Treating osteomyelitis: antibiotics and surgery. Plast. Reconstr. Surg. 2011, 127(Suppl. 1):177S-187S.
57. Rasigade J.P., Trouillet-Assant S., Ferry T., Diep B.A., Sapin A., Lhoste Y., Ranfaing J., Badiou C., Benito Y., Bes M., Couzon F., Tigaud S., Lina G., Etienne J., Vandenesch F., Laurent F. PSMs of hypervirulent Staphylococcus aureus act as intracellular toxins that kill infected osteoblasts. PLoS ONE 2013, 8:e63176.
58. Ridley R.A., Douglas I., Whawell S.A. Differential adhesion and invasion by Staphylococcus aureus of epithelial cells derived from different anatomical sites. J. Med. Microbiol. 2012, 61:1654-1661.
59. Schnaith A., Kashkar H., Leggio S.A., Addicks K., Kronke M., Krut O. Staphylococcus aureus subvert autophagy for induction of caspase-independent host cell death. J. Biol. Chem. 2007, 282:2695-2706.
60. Seidl K., Solis N.V., Bayer A.S., Hady W.A., Ellison S., Klashman M.C., Xiong Y.Q., Filler S.G. Divergent responses of different endothelial cell types to infection with Candida albicans and Staphylococcus aureus. PLoS ONE 2012, 7:e39633.
61. Sendi P., Proctor R.A. Staphylococcus aureus as an intracellular pathogen: the role of small colony variants. Trends Microbiol. 2009, 17:54-58.
62. Shopsin B., Drlica-Wagner A., Mathema B., Adhikari R.P., Kreiswirth B.N., Novick R.P. Prevalence of agr dysfunction among colonizing Staphylococcus aureus strains. J. Infect. Dis. 2008, 198:1171-1174.
63. Sinha B., Francois P., Que Y.A., Hussain M., Heilmann C., Moreillon P., Lew D., Krause K.H., Peters G., Herrmann M. Heterologously expressed Staphylococcus aureus fibronectin-binding proteins are sufficient for invasion of host cells. Infect. Immun. 2000, 68:6871-6878.
64. Sinha B., Francois P.P., Nüsse O., Foti M., Hartford O.M., Vaudaux P., Foster T.J., Lew D.P., Herrmann M., Krause K.H. Fibronectin-binding protein acts as Staphylococcus aureus invasin via fibronectin bridging to integrin alpha5beta1. Cell Microbiol. 1999, 1:101-117.
65. Soong G., Chun J., Parker D., Prince A. Staphylococcus aureus activation of caspase 1/calpain signaling mediates invasion through human keratinocytes. J. Infect. Dis. 2012, 205:1571-1579.
66. Soong G., Martin F.J., Chun J., Cohen T.S., Ahn D.S., Prince A. Staphylococcus aureus protein A mediates invasion across airway epithelial cells through activation of RhoA GTPase signaling and proteolytic activity. J. Biol. Chem. 2011, 286:35891-35898.
67. Surewaard B.G., Nijland R., Spaan A.N., Kruijtzer J.A., de Haas C.J., van Strijp J.A. Inactivation of staphylococcal phenol soluble modulins by serum lipoprotein particles. PLoS Pathog. 2012, 8:e1002606.
68. Tuchscherr L., Heitmann V., Hussain M., Viemann D., Roth J., von Eiff C., Peters G., Becker K., Löffler B. Staphylococcus aureus small-colony variants are adapted phenotypes for intracellular persistence. J. Infect. Dis. 2010, 202:1031-1040.
69. Tuchscherr L., Medina E., Hussain M., Völker W., Heitmann V., Niemann S., Holzinger D., Roth J., Proctor R.A., Becker K., Peters G., Löffler B. Staphylococcus aureus phenotype switching: an effective bacterial strategy to escape host immune response and establish a chronic infection. EMBO Mol. Med. 2011, 3:129-141.
70. Tuchscherr L.P., Buzzola F.R., Alvarez L.P., Lee J.C., Sordelli D.O. Antibodies to capsular polysaccharide and clumping factor A prevent mastitis and the emergence of unencapsulated and small-colony variants of Staphylococcus aureus in mice. Infect. Immun. 2008, 76:5738-5744.
71. Van Bambeke F., Barcia-Macay M., Lemaire S., Tulkens P.M. Cellular pharmacodynamics and pharmacokinetics of antibiotics: current views and perspectives. Curr. Opin. Drug Discov. Devel. 2006, 9:218-230.
72. Vandenesch F., Lina G., Henry T. Staphylococcus aureus hemolysins, bi-component leukocidins, and cytolytic peptides: a redundant arsenal of membrane-damaging virulence factors?. Front. Cell Infect. Microbiol. 2012, 2:12.
73. Vaudaux P., Francois P., Bisognano C., Kelley W.L., Lew D.P., Schrenzel J., Proctor R.A., McNamara P.J., Peters G., von Eiff C. Increased expression of clumping factor and fibronectin-binding proteins by hemB mutants of Staphylococcus aureus expressing small colony variant phenotypes. Infect. Immun. 2002, 70:5428-5437.
74. Vesga O., Groeschel M.C., Otten M.F., Brar D.W., Vann J.M., Proctor R.A. Staphylococcus aureus small colony variants are induced by the endothelial cell intracellular milieu. J. Infect. Dis. 1996, 173:739-742.
75. von Eiff C., Becker K., Metze D., Lubritz G., Hockmann J., Schwarz T., Peters G. Intracellular persistence of Staphylococcus aureus small-colony variants within keratinocytes: a cause for antibiotic treatment failure in a patient with darier's disease. Clin. Infect. Dis. 2001, 32:1643-1647.
76. von Eiff C., McNamara P., Becker K., Bates D., Lei X.H., Ziman M., Bochner B.R., Peters G., Proctor R.A. Phenotype microarray profiling of Staphylococcus aureus menD and hemB mutants with the small-colony-variant phenotype. J. Bacteriol. 2006, 188:687-693.
77. von Eiff C., Friedrich A.W., Becker K., Peters G. Comparative in vitro activity of ceftobiprole against staphylococci displaying normal and small-colony variant phenotypes. Antimicrob. Agents Chemother. 2005, 49:4372-4374.
78. von Eiff C., Heilmann C., Proctor R.A., Woltz C., Peters G., Götz F. A site-directed Staphylococcus aureus hemB mutant is a small-colony variant which persists intracellularly. J. Bacteriol. 1997, 179:4706-4712.
79. von Eiff C., Peters G., Becker K. The small colony variant (SCV) concept - the role of staphylococcal SCVs in persistent infections. Injury 2006, 37(Suppl. 2):S26-S33.
80. Wang R., Braughton K.R., Kretschmer D., Bach T.H., Queck S.Y., Li M., Kennedy A.D., Dorward D.W., Klebanoff S.J., Peschel A., Deleo F.R., Otto M. Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat. Med. 2007, 13:1510-1514.
81. Wright J.A., Nair S.P. Interaction of staphylococci with bone. Int. J. Med. Microbiol. 2010, 300:193-204.
82. Ziegler C., Goldmann O., Hobeika E., Geffers R., Peters G., Medina E. The dynamics of T cells during persistent Staphylococcus aureus infection: from antigen-reactivity to in vivo anergy. EMBO Mol. Med. 2011, 3:652-666.